We Are Currently Accepting New Sites!
Contact us for more information about becoming a site for the TACT2 trial.
We have identified more than 100 clinical sites in the United States and Canada that wish to participate in TACT2 and continue to accept new site applications.
The results of the TACT1 trial were at first met with some skepticism within the academic research community, but as the results have been published, that skepticism is fading. There is intense curiosity and excitement about the potential of chelation therapy and a desire to be a part of the TACT2 trial. Please read more about the TACT studies or contact us for more information about becoming a clinical site.